Related Experiment Video
Updated: Nov 30, 2025

Diagnosis of Neoplasia in Barrett’s Esophagus using Vital-dye Enhanced Fluorescence Imaging
Published on: May 11, 2014
Imaging biomarkers in upper gastrointestinal cancers
Michela Gabelloni1, Lorenzo Faggioni1, Emanuele Neri1
1Department of Translational Research, Diagnostic and Interventional Radiology, University of Pisa, Pisa, Italy.
Imaging biomarkers offer quantitative data for upper gastrointestinal cancers, improving diagnosis, staging, and treatment planning. This review explores their current applications and future potential in patient management.
Area of Science:
- Oncology
- Radiology
- Medical Imaging
Background:
- Advancements in imaging technology and understanding of gastrointestinal malignancies are driving innovation.
- Conventional imaging lacks quantitative data crucial for personalized patient care.
- Imaging biomarkers present an opportunity to enhance diagnostic accuracy and treatment strategies.
Purpose of the Study:
- To review the current state of knowledge on imaging biomarkers for upper gastrointestinal cancers.
- To highlight the potential applications of these biomarkers in clinical practice.
- To discuss future perspectives for integrating imaging biomarkers into patient management.
Main Methods:
- Literature review of recent advancements in imaging biomarkers for upper gastrointestinal cancers.
- Analysis of the role of quantitative imaging data in diagnosis, staging, and follow-up.
- Exploration of biomarker-guided treatment planning and outcome prediction.
Main Results:
- Imaging biomarkers provide valuable quantitative information beyond conventional imaging.
- They show potential in improving the accuracy of staging and follow-up assessments.
- Biomarkers can aid in predicting patient outcomes and personalizing treatment strategies.
Conclusions:
- Imaging biomarkers are crucial for advancing the management of upper gastrointestinal cancers.
- Their integration into clinical workflows promises improved patient outcomes.
- Further research is needed to fully realize their potential in personalized oncology.
More Related Videos
10:28Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
07:05Important Endpoints and Proliferative Markers to Assess Small Intestinal Injury and Adaptation using a Mouse Model of Chemotherapy-Induced Mucositis
Published on: May 12, 2019
Related Concept Videos
Imaging Studies III: Gastrointestinal Motility Studies and Virtual Colonoscopy
Radionuclide Testing
Radionuclide testing is a sophisticated medical technique for assessing gastrointestinal motility. It focuses on gastric emptying and colonic transit time. Radioactive markers track the movement of food through the digestive system, providing insights into gastrointestinal disorders.
In gastric emptying studies, a meal's liquid and...
Upper GI Series: Barium Swallow
Purpose and Procedure
Patients undergoing this procedure ingest a liquid containing barium sulfate with a chalky...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Imaging Studies IV: Magnetic Resonance Imaging
Serum Laboratory Studies, Stool Test, Breath Test
Imaging Studies II: Positron Emission Tomography and Scintigraphy
Fundamental Principles of PET